128 related articles for article (PubMed ID: 14756095)
1. [Physicians' travels abroad supported by drug industry scrutinized. Three cases surveyed by the IGM and the NBL].
Perman E
Lakartidningen; 2003 Dec; 100(51-52):4298-9. PubMed ID: 14756095
[No Abstract] [Full Text] [Related]
2. [Physicians report verbal drug information. Cases scrutinized by the IGM].
Perman E
Lakartidningen; 2004 Aug; 101(35):2648, 2650. PubMed ID: 15458219
[No Abstract] [Full Text] [Related]
3. [Physicians and drug industry: attitudes and practice].
Aasland OG; Førde R
Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2603-6. PubMed ID: 15534631
[TBL] [Abstract][Full Text] [Related]
4. [Physicians notify on drug industry's marketing].
Perman E
Lakartidningen; 2004 Mar; 101(11):1014-5. PubMed ID: 15055124
[No Abstract] [Full Text] [Related]
5. The Physicians' Desk Reference. Problems and possible improvements.
Cohen JS; Insel PA
Arch Intern Med; 1996 Jul; 156(13):1375-80. PubMed ID: 8678706
[TBL] [Abstract][Full Text] [Related]
6. [Free lunch and samples are not bribes].
Lagerlöf O
Lakartidningen; 2003 Nov; 100(48):4017. PubMed ID: 14717103
[No Abstract] [Full Text] [Related]
7. [A bribe to be at a drug industry-consultant's disposal?].
Hernborg A
Lakartidningen; 2002 Apr; 99(15):1729. PubMed ID: 12025205
[No Abstract] [Full Text] [Related]
8. [Scrutiny of drug marketing by drug industry].
Perman E
Lakartidningen; 2003 Apr; 100(16):1444-5. PubMed ID: 12756713
[No Abstract] [Full Text] [Related]
9. Conflict of interest in the physician interface with the biomedical industry.
Minnigan H; Chisholm CD
Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
[TBL] [Abstract][Full Text] [Related]
10. [Drug information on better conditions].
Rolfs M; Johansson P
Lakartidningen; 2009 Mar 4-10; 106(10):655. PubMed ID: 19418682
[No Abstract] [Full Text] [Related]
11. [Whitewashing of drug information by the state].
Reseland S
Tidsskr Nor Laegeforen; 2010 Feb; 130(4):368. PubMed ID: 20220857
[No Abstract] [Full Text] [Related]
12. [Public drug marketing scrutinized by IGM and NBL. Conviction in four cases].
Perman E
Lakartidningen; 2005 Apr 18-24; 102(16):1262. PubMed ID: 15921101
[No Abstract] [Full Text] [Related]
13. [Something for something--physicians, drug industry and general welfare].
Bro F; Olesen F
Ugeskr Laeger; 2006 Nov; 168(46):3985. PubMed ID: 17125648
[No Abstract] [Full Text] [Related]
14. [Physicians and drug industry].
Hallager K
Ugeskr Laeger; 2004 May; 166(21):2069. PubMed ID: 15222087
[No Abstract] [Full Text] [Related]
15. [Drug companies and continuing education].
Hotvedt R
Tidsskr Nor Laegeforen; 2005 Aug; 125(15):2043. PubMed ID: 16100551
[No Abstract] [Full Text] [Related]
16. [Pharmaceutical consultants don't give neutral information].
Reseland S
Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2620. PubMed ID: 19023368
[No Abstract] [Full Text] [Related]
17. [Doctors and the drug industry].
Gudmundsson S
Laeknabladid; 2005 Mar; 91(3):234. PubMed ID: 16155323
[No Abstract] [Full Text] [Related]
18. [Physicians and drug industry--one more time].
Rørtveit G
Tidsskr Nor Laegeforen; 2008 Feb; 128(5):553. PubMed ID: 18311195
[No Abstract] [Full Text] [Related]
19. [Physicians with Narrower Limits].
Aagaard E
Ugeskr Laeger; 2007 Nov; 169(46):3984; author reply 3984. PubMed ID: 18087786
[No Abstract] [Full Text] [Related]
20. [Objective counseling concerning drugs and drug research].
Mehlsen J
Ugeskr Laeger; 2003 Dec; 165(51):4980-1; author reply 4981. PubMed ID: 14727416
[No Abstract] [Full Text] [Related]
[Next] [New Search]
